Compare RDY & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDY | COKE |
|---|---|---|
| Founded | 1984 | 1902 |
| Country | India | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 13.4B |
| IPO Year | 2001 | 1994 |
| Metric | RDY | COKE |
|---|---|---|
| Price | $13.71 | $204.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $16.90 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 335.6K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.52% | 0.50% |
| EPS Growth | N/A | ★ 156.81 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | ★ $7,228,055,000.00 |
| Revenue This Year | $7.72 | N/A |
| Revenue Next Year | $3.50 | N/A |
| P/E Ratio | ★ $18.67 | $169.91 |
| Revenue Growth | N/A | ★ 4.76 |
| 52 Week Low | $12.77 | $105.21 |
| 52 Week High | $16.17 | $1,202.60 |
| Indicator | RDY | COKE |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 60.12 |
| Support Level | $12.90 | $145.64 |
| Resistance Level | $13.96 | $209.36 |
| Average True Range (ATR) | 0.26 | 5.72 |
| MACD | 0.10 | 1.54 |
| Stochastic Oscillator | 65.38 | 89.56 |
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.